The content on this site is intended for healthcare professionals only
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for ...
Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, US...
1 Mar 2010
ASH 2009: New treatments for multiple myeloma
Prof Antonio Palumbo - University of Torino, Italy
1 Mar 2010
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma
Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain
1 Mar 2010
ASH 2009: New regimens for elderly multiple myeloma patients
Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
1 Mar 2010
ASH 2009: Tackling polyneuropathy associated with bortezomib
Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands
1 Mar 2010
ASH 2009: Novel agents for multiple myeloma
Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA
1 Mar 2010
Adult acute lymphoblastic leukaemia
Prof Anthony Goldstone - Director, North London Cancer Network
27 Jan 2010
T-cell therapies
Dr Catherine Bollard - Baylor College of Medicine, Texas, USA
27 Jan 2010
Myeloid supressor cells
Prof John Harlan - University of Washington, USA
27 Jan 2010
Studies comparing treatments for lymphoma
Dr Mathias Rummel - University Hospital, Giessen, Germany
27 Jan 2010
New target for myeloma
Dr Teru Hideshima - Principal Associate in Medicine, Harvard Medical School
27 Jan 2010
Multiple myeloma news from ASH 2009
Prof Gordon McVie - ecancer managing editor
20 Jan 2010
